BPH Surgical Treatment Market by Type (TURP, Laser, Rezum, Urolift, Ablation, PAE), Drug Type (Alpha Blocker (Alfuzosin), Alpha Reductase Inhibitor (Dutastride), Therapy (Mono, Combination), End Users (Hospitals) - Global Forecast to 2030

1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Market Scope
1.3.2 Inclusions & Exclusions
1.3.3 Years Considered
1.3.4 Currency Considered
1.4 Stakeholders
1.5 Limitations
1.6 Summary of Changes

2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data from Secondary Sources
2.1.2 Primary Data
2.1.2.1 Primary Sources
2.1.2.2 Key Data from Primary Sources
2.1.2.3 Key Industry Insights
2.1.2.4 Breakdown of Primary Interviews
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.1.1 Approach 1: Company Revenue Estimation Approach, by Type
2.2.1.2 Approach 1: Company Revenue Estimation Approach, by Drug Type
2.2.2 Top-Down Approach
2.3 Market Breakdown & Data Triangulation
2.4 Market Share Analysis
2.4.1 Study Assumptions
2.4.2 Growth Rate Assumptions
2.5 Research Limitations
2.5.1 Methodology-Related Limitations
2.5.2 Scope-Related Limitations
2.6 Risk Assessment

4.1 Bph Surgical Treatment Market Overview
4.2 North America: Bph Surgical Treatment Market, by Drug Type and Country (2024)
4.3 Bph Surgical Treatment Market: Geographic Growth Opportunities
4.4 Bph Surgical Treatment Market: Regional Mix (2024-2030)

5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Expanding Aging Population and Increasing Prevalence of Benign Prostatic Hyperplasia
5.2.1.2 Rising Cases of Obesity in Males
5.2.1.3 Growing Preference for Minimally Invasive Surgeries
5.2.2 Restraints
5.2.2.1 Side Effects Associated with Bph Medications
5.2.2.2 High Cost of Bph Surgical Treatment
5.2.3 Opportunities
5.2.3.1 High Growth Potential of Emerging Economies
5.2.3.2 Favorable Funding Investments for Bhp Drug Development
5.2.4 Challenges
5.2.4.1 Shortage of Skilled Professionals
5.2.4.2 Low Awareness Regarding Prostate Health
5.2.4.3 Product Recalls
5.3 Value Chain Analysis
5.4 Supply Chain Analysis
5.5 Ecosystem Analysis
5.6 Porter's Five Forces Analysis
5.6.1 Threat of New Entrants
5.6.2 Threat of Substitutes
5.6.3 Bargaining Power of Buyers
5.6.4 Bargaining Power of Suppliers
5.6.5 Intensity of Competitive Rivalry
5.7 Key Stakeholders & Buying Criteria
5.7.1 Key Stakeholders in Buying Process
5.7.2 Buying Criteria
5.8 Regulatory Scenario
5.8.1 Pharmaceutical Industry
5.8.1.1 Regulatory Requirements
5.8.1.1.1 EU Regulations
5.8.1.1.2 US Regulations
5.8.2 Medical Devices Industry
5.8.2.1 US
5.8.2.2 Canada
5.8.2.3 Europe
5.8.2.4 Asia-Pacific
5.8.2.4.1 Japan
5.8.2.4.2 China
5.8.2.4.3 India
5.8.2.5 Latin America
5.8.2.5.1 Brazil
5.8.2.5.2 Mexico
5.8.2.6 Middle East
5.8.2.7 Africa
5.8.3 List of Regulatory Bodies, Government Agencies, and Other Organizations
5.9 Pricing Analysis
5.9.1 Average Selling Price Trend for Urolift, by Region, 2021-2023
5.9.2 Average Selling Pricing Trend for Avodart, by Region, 2021-2023
5.9.3 Average Selling Pricing Trend for Bph Surgical Treatment Procedures, 2021-2023
5.10 Technology Analysis
5.10.1 Key Technologies
5.10.1.1 Minimally Invasive Surgical Techniques
5.10.2 Complementary Technologies
5.10.2.1 Robotic & AI-Assisted Surgical Systems
5.10.3 Adjacent Technologies
5.10.3.1 MRI-Ultrasound Imaging
5.11 PESTLE Analysis
5.12 Patent Analysis
5.13 Trade Analysis
5.13.1 Trade Analysis for Endoscopes
5.13.2 Trade Analysis for Tadalafil
5.14 Key Conferences & Events, 2025-2026
5.15 Trends/Disruptions Impacting Customers’ Businesses
5.16 Impact of Generative AI/AI on Bph Surgical Treatment Market
5.17 Investment & Funding Scenario

6.1 Introduction
6.1.1 Alpha-Blockers
6.1.1.1 Tamsulosin
6.1.1.1.1 Oldest Prescribed Drug with Minimal Effects on Blood Pressure to Fuel Uptake
6.1.1.2 Silodosin
6.1.1.2.1 Launch of Generics to Boost Demand
6.1.1.3 Alfuzosin
6.1.1.3.1 Associated Side Effects to Restrain Market Adoption
6.1.1.4 Doxazosin
6.1.1.4.1 Ability to Provide Long-Term Results to Fuel Uptake
6.1.1.5 Other Alpha-Blockers
6.1.2 5-Alpha Reductase Inhibitors
6.1.2.1 Dutasteride
6.1.2.1.1 Slow But Gradual Reduction in Symptoms to Boost Demand
6.1.2.2 Finasteride
6.1.2.2.1 Ability to Decrease Psa Levels to Support Market Growth
6.1.3 Other Drug Types

7.1 Introduction
7.1.1 Transurethral Resection of the Prostate (Turp)
7.1.1.1 Gold Standard for Bph Treatment to Boost Demand
7.1.2 Laser Surgeries
7.1.2.1 Evolution in Lasers and High Efficacy to Boost Demand
7.1.3 Urolift Procedures
7.1.3.1 High Safety and Convenience to Boost Demand
7.1.4 Rezum Procedures
7.1.4.1 Convenience of Being Conducted in Outpatient Settings to Support Market Growth
7.1.5 Robot-Assisted Waterjet Ablation
7.1.5.1 Advanced Real-Time Capabilities with Image-Guided Features to Propel Market
7.1.6 Prostatic Stents
7.1.6.1 Temporarily Designed for Short-Term Use to Support Market Growth
7.1.7 Transurethral Microwave Thermotherapy (Tumt)
7.1.7.1 Lower Risk of Bleeding Without Hospitalization to Fuel Market
7.1.8 Transurethral Needle Ablation of the Prostate (Tuna)
7.1.8.1 Favorable Reimbursement Policies to Boost Demand
7.1.9 Prostatic Arterial Embolization (Pae)
7.1.9.1 Minimally Invasive Technique to Fuel Uptake
7.1.10 Other Procedures

8.1 Introduction
8.2 Monotherapy
8.2.1 Utilization of Single Medication to Propel Market
8.3 Combination Drug Therapy
8.3.1 High Utilization for Patients with Rapid Progression Rates to Drive Market

9.1 Introduction
9.2 Hospitals
9.2.1 High Purchasing Power for Advanced Bph Surgical Equipment to Drive Market
9.3 Ambulatory Surgery Centers & Clinics
9.3.1 Lower Cost and Shorter Patient Stays to Propel Market
9.4 Home Care Settings
9.4.1 Convenience and Cost-Efficient Benefits to Fuel Market

10.1 Introduction
10.2 North America
10.2.1 Macroeconomic Outlook for North America
10.2.2 US
10.2.2.1 Presence of Key Medical Device Manufacturers to Boost Demand
10.2.3 Canada
10.2.3.1 Favorable Federal Funding for Advanced Bph Products to Fuel Market
10.3 Europe
10.3.1 Macroeconomic Outlook for Europe
10.3.2 Germany
10.3.2.1 Increasing Healthcare Expenditure to Drive Market
10.3.3 UK
10.3.3.1 Availability of Innovative Treatment Options for Utis to Drive Market
10.3.4 France
10.3.4.1 Favorable Private & Public Healthcare Investments to Fuel Market
10.3.5 Italy
10.3.5.1 Rising Geriatric Population and Subsequent Rise in Obesity to Propel Market
10.3.6 Spain
10.3.6.1 Increasing Uptake of Urolift Procedures to Drive Market
10.3.7 Rest of Europe
10.4 Asia-Pacific
10.4.1 Macroeconomic Outlook for Asia-Pacific
10.4.2 Japan
10.4.2.1 Mandatory Health Insurance Programs to Fuel Uptake
10.4.3 China
10.4.3.1 Rising Demand for Diagnostic Procedures to Drive Market
10.4.4 India
10.4.4.1 Expanding Target Patient Population to Drive Market
10.4.5 Australia
10.4.5.1 High Prevalence of Obesity to Support Market Growth
10.4.6 Rest of Asia-Pacific
10.5 Latin America
10.5.1 Macroeconomic Outlook for Latin America
10.5.2 Brazil
10.5.2.1 Rising Incidence of Cancer to Support Market Growth
10.5.3 Mexico
10.5.3.1 Popularity in Medical Tourism to Drive Market
10.5.4 Rest of Latin America
10.6 Middle East & Africa
10.6.1 Demand for Advanced Healthcare Diagnostics to Fuel Uptake
10.6.2 Macroeconomic Outlook for Middle East & Africa
10.7 GCC Countries
10.7.1 Rising Healthcare Budgets and Growing Awareness of Bph to Support Market Growth
10.7.2 Macroeconomic Outlook for GCC Countries

11.1 Overview
11.2 Key Player Strategies/Right to Win
11.2.1 Overview of Strategies Deployed by Players in Bph Surgical Treatment Market
11.3 Revenue Analysis, 2021-2023
11.4 Market Share Analysis, 2023
11.5 Company Evaluation Matrix, by Drug Type: Key Players, 2023
11.5.1 Stars
11.5.2 Emerging Leaders
11.5.3 Pervasive Players
11.5.4 Participants
11.6 Company Evaluation Matrix, by Type: Key Players, 2023
11.6.1 Stars
11.6.2 Emerging Leaders
11.6.3 Pervasive Players
11.6.4 Participants
11.6.5 Company Footprint: Key Players (Drug Type and Type), 2023
11.6.5.1 Company Footprint
11.6.5.2 Region Footprint
11.6.5.3 Drug Type Footprint
11.6.5.4 Type Footprint
11.6.5.5 End-user Footprint
11.7 Company Evaluation Matrix: Startups/SMEs, 2023
11.7.1 Progressive Companies
11.7.2 Responsive Companies
11.7.3 Dynamic Companies
11.7.4 Starting Blocks
11.7.5 Competitive Benchmarking: Startups/SMEs, 2023
11.7.5.1 Detailed List of Key Startups/SMEs
11.7.5.2 Competitive Benchmarking of Key Startups
11.8 Company Valuation & Financial Metrics
11.9 Brand/Product Comparison
11.10 Competitive Scenario
11.10.1 Product Launches & Approvals
11.10.2 Deals
11.10.3 Expansions

12.1 Key Players
12.1.1 GlaxoSmithKline PLC
12.1.1.1 Business Overview
12.1.1.2 Products Offered
12.1.1.3 Recent Developments
12.1.1.3.1 Deals
12.1.1.4 Analyst's View
12.1.1.4.1 Key Strengths
12.1.1.4.2 Strategic Choices
12.1.1.4.3 Weaknesses & Competitive Threats
12.1.2 Eli Lilly and Company
12.1.2.1 Business Overview
12.1.2.2 Products Offered
12.1.2.3 Recent Developments
12.1.2.3.1 Deals
12.1.2.4 Analyst's View
12.1.2.4.1 Key Strengths
12.1.2.4.2 Strategic Choices
12.1.2.4.3 Weaknesses & Competitive Threats
12.1.3 Teleflex Incorporated
12.1.3.1 Business Overview
12.1.3.2 Products Offered
12.1.3.3 Recent Developments
12.1.3.3.1 Product Launches & Approvals
12.1.3.4 Analyst's View
12.1.3.4.1 Key Strengths
12.1.3.4.2 Strategic Choices
12.1.3.4.3 Weaknesses & Competitive Threats
12.1.4 Boston Scientific Corporation
12.1.4.1 Business Overview
12.1.4.2 Recent Developments
12.1.4.2.1 Deals
12.1.4.2.2 Expansions
12.1.4.3 Analyst's View
12.1.4.3.1 Key Strengths
12.1.4.3.2 Strategic Choices
12.1.4.3.3 Weaknesses & Competitive Threats
12.1.5 Procept Biorobotics Corporation
12.1.5.1 Business Overview
12.1.5.2 Products Offered
12.1.5.3 Recent Developments
12.1.5.3.1 Product Approvals
12.1.5.3.2 Expansions
12.1.5.4 Analyst's View
12.1.5.4.1 Key Strengths
12.1.5.4.2 Strategic Choices
12.1.5.4.3 Weaknesses & Competitive Threats
12.1.6 Astellas Pharma Inc.
12.1.6.1 Business Overview
12.1.6.2 Products Offered
12.1.7 Alembic Pharmaceuticals Limited
12.1.7.1 Business Overview
12.1.7.2 Products Offered
12.1.8 Asahi Kasei Corporation
12.1.8.1 Business Overview
12.1.8.2 Products Offered
12.1.9 Organon & Co.
12.1.9.1 Business Overview
12.1.9.2 Products Offered
12.1.9.3 Recent Developments
12.1.9.3.1 Deals
12.1.10 Olympus Corporation
12.1.10.1 Business Overview
12.1.10.2 Products Offered
12.1.10.3 Recent Developments
12.1.10.3.1 Deals
12.1.11 Coloplast Group
12.1.11.1 Business Overview
12.1.11.2 Products Offered
12.1.12 Ipg Photonics Corporation
12.1.12.1 Business Overview
12.1.12.2 Products Offered
12.1.13 Viatris Inc.
12.1.13.1 Business Overview
12.1.13.2 Products Offered
12.1.14 Abbvie Inc.
12.1.14.1 Business Overview
12.1.14.2 Products Offered
12.1.14.3 Recent Developments
12.1.14.3.1 Deals
12.1.15 Prostalund Ab
12.1.15.1 Business Overview
12.1.15.2 Products Offered
12.2 Other Players
12.2.1 Karl Storz SE & Co. KG
12.2.2 Richard Wolf GmbH
12.2.3 Unilab, Inc.
12.2.4 Biolitec Holding GmbH & Co KG
12.2.5 Urologix, LLC.
12.2.6 Advin Health Care
12.2.7 Medifocus, Inc.
12.2.8 Jenasurgical (Asclepion Laser Technologies GmbH)
12.2.9 Pnn Medical A/S
12.2.10 Surgical Lasers Inc.
12.2.11 Quanta System
12.2.12 Allium Ltd.
12.2.13 Srs Medical
12.2.14 Laborie Medical Technologies
12.2.15 Cook Medical

13.1 Knowledgestore: The Subscription Portal
13.2 Customization Options

Table 1 Bph Surgical Treatment Market: Risk Assessment Analysis
Table 2 Associated Side Effects of Bph Drugs
Table 3 Product Recalls in Bph Treatment Market
Table 4 Bph Surgical Treatment Market: Role of Companies in Ecosystem
Table 5 Bph Surgical Treatment Market: Porter's Five Forces Factor Analysis
Table 6 Influence of Stakeholders on Buying Process, by End-user
Table 7 Key Buying Criteria (Ranking) for Bph Surgical Treatment Market, by End-user
Table 8 US Fda: Medical Device Classification
Table 9 US: Medical Device Regulatory Approval Process
Table 10 Canada: Medical Device Regulatory Approval Process
Table 11 Japan: Medical Device Classification Under Pmda
Table 12 China: Classification of Medical Devices
Table 13 North America: List of Regulatory Bodies, Government Agencies, and Other Organizations
Table 14 Europe: List of Regulatory Bodies, Government Agencies, and Other Organizations
Table 15 Asia-Pacific: List of Regulatory Bodies, Government Agencies, and Other Organizations
Table 16 Latin America: List of Regulatory Bodies, Government Agencies, and Other Organizations
Table 17 Rest of the World: List of Regulatory Bodies, Government Agencies, and Other Organizations
Table 18 Average Selling Price Trend for Urolift, by Region, 2021-2023
Table 19 Average Selling Price Trend of Dutasteride (Avodart), by Region, 2021-2023
Table 20 Average Selling Pricing Trend for Bph Surgical Treatment Procedures, 2021-2023
Table 21 Import Data for Endoscopes (Value) by Country, 2019-2023 (USD Thousand)
Table 22 Export Data for Endoscopes (Value) by Country, 2019-2023 (USD Thousand)
Table 23 Import Data for Tadalafil (Value) by Country, 2019-2023 (USD Thousand)
Table 24 Export Data for Tadalafil (Value) by Country, 2019-2023 (USD Thousand)
Table 25 Bph Surgical Treatment Market: Key Conferences & Events, 2025-2026
Table 26 Bph Surgical Treatment Market, by Drug Type, 2022-2030 (USD Million)
Table 27 Bph Drug Type Market, by Region, 2022-2030 (USD Million)
Table 28 North America: Bph Drug Type Market, by Country, 2022-2030 (USD Million)
Table 29 Europe: Bph Drug Type Market, by Country, 2022-2030 (USD Million)
Table 30 Asia-Pacific: Bph Drug Type Market, by Country, 2022-2030 (USD Million)
Table 31 Latin America: Bph Drug Type Market, by Country, 2022-2030 (USD Million)
Table 32 Alpha-Blockers Market, by Type, 2022-2030 (USD Million)
Table 33 Alpha-Blockers Market, by Region, 2022-2030 (USD Million)
Table 34 North America: Alpha-Blockers Market, by Country, 2022-2030 (USD Million)
Table 35 Europe: Alpha-Blockers Market, by Country, 2022-2030 (USD Million)
Table 36 Asia-Pacific: Alpha-Blockers Market, by Country, 2022-2030 (USD Million)
Table 37 Latin America: Alpha-Blockers Market, by Country, 2022-2030 (USD Million)
Table 38 Alpha-Blockers Market for Tamsulosin, by Region, 2022-2030 (USD Million)
Table 39 North America: Alpha-Blockers Market for Tamsulosin, by Country, 2022-2030 (USD Million)
Table 40 Europe: Alpha-Blockers Market for Tamsulosin, by Country, 2022-2030 (USD Million)
Table 41 Asia-Pacific: Alpha-Blockers Market for Tamsulosin, by Country, 2022-2030 (USD Million)
Table 42 Latin America: Alpha-Blockers Market for Tamsulosin, by Country, 2022-2030 (USD Million)
Table 43 Alpha-Blockers Market for Silodosin, by Region, 2022-2030 (USD Million)
Table 44 North America: Alpha-Blockers Market for Silodosin, by Country, 2022-2030 (USD Million)
Table 45 Europe: Alpha-Blockers Market for Silodosin, by Country, 2022-2030 (USD Million)
Table 46 Asia-Pacific: Alpha-Blockers Market for Silodosin, by Country, 2022-2030 (USD Million)
Table 47 Latin America: Alpha-Blockers Market for Silodosin, by Country, 2022-2030 (USD Million)
Table 48 Alpha-Blockers Market for Alfuzosin, by Region, 2022-2030 (USD Million)
Table 49 North America: Alpha-Blockers Market for Alfuzosin, by Country, 2022-2030 (USD Million)
Table 50 Europe: Alpha-Blockers Market for Alfuzosin, by Country, 2022-2030 (USD Million)
Table 51 Asia-Pacific: Alpha-Blockers Market for Alfuzosin, by Country, 2022-2030 (USD Million)
Table 52 Latin America: Alpha-Blockers Market for Alfuzosin, by Country, 2022-2030 (USD Million)
Table 53 Alpha-Blockers Market for Doxazosin, by Region, 2022-2030 (USD Million)
Table 54 North America: Alpha-Blockers Market for Doxazosin, by Country, 2022-2030 (USD Million)
Table 55 Europe: Alpha-Blockers Market for Doxazosin, by Country, 2022-2030 (USD Million)
Table 56 Asia-Pacific: Alpha-Blockers Market for Doxazosin, by Country, 2022-2030 (USD Million)
Table 57 Latin America: Alpha-Blockers Market for Doxazosin, by Country, 2022-2030 (USD Million)
Table 58 Other Alpha-Blockers Market, by Region, 2022-2030 (USD Million)
Table 59 North America: Other Alpha-Blockers Market, by Country, 2022-2030 (USD Million)
Table 60 Europe: Other Alpha-Blockers Market, by Country, 2022-2030 (USD Million)
Table 61 Asia-Pacific: Other Alpha-Blockers Market, by Country, 2022-2030 (USD Million)
Table 62 Latin America: Other Alpha-Blockers Market, by Country, 2022-2030 (USD Million)
Table 63 5-Alpha Reductase Inhibitors Market, by Type, 2022-2030 (USD Million)
Table 64 5-Alpha Reductase Inhibitors Market, by Region, 2022-2030 (USD Million)
Table 65 North America: 5-Alpha Reductase Inhibitors Market, by Country, 2022-2030 (USD Million)
Table 66 Europe: 5-Alpha Reductase Inhibitors Market, by Country, 2022-2030 (USD Million)
Table 67 Asia-Pacific: 5-Alpha Reductase Inhibitors Market, by Country, 2022-2030 (USD Million)
Table 68 Latin America: 5-Alpha Reductase Inhibitors Market, by Country, 2022-2030 (USD Million)
Table 69 5-Alpha Reductase Inhibitors for Dutasteride Market, by Region, 2022-2030 (USD Million)
Table 70 North America: 5-Alpha Reductase Inhibitors Market for Dutasteride, by Country, 2022-2030 (USD Million)
Table 71 Europe: 5-Alpha Reductase Inhibitors Market for Dutasteride, by Country, 2022-2030 (USD Million)
Table 72 Asia-Pacific: 5-Alpha Reductase Inhibitors Market for Dutasteride, by Country, 2022-2030 (USD Million)
Table 73 Latin America: 5-Alpha Reductase Inhibitors Market for Dutasteride, by Country, 2022-2030 (USD Million)
Table 74 5-Alpha Reductase Inhibitors Market for Finasteride, by Region, 2022-2030 (USD Million)
Table 75 North America: 5-Alpha Reductase Inhibitors Market for Finasteride, by Country, 2022-2030 (USD Million)
Table 76 Europe: 5-Alpha Reductase Inhibitors Market for Finasteride, by Country, 2022-2030 (USD Million)
Table 77 Asia-Pacific: 5-Alpha Reductase Inhibitors Market for Finasteride, by Country, 2022-2030 (USD Million)
Table 78 Latin America: 5-Alpha Reductase Inhibitors Market for Finasteride, by Country, 2022-2030 (USD Million)
Table 79 Other Drug Types Market, by Region, 2022-2030 (USD Million)
Table 80 North America: Other Drug Types Market, by Country, 2022-2030 (USD Million)
Table 81 Europe: Other Drug Types Market, by Country, 2022-2030 (USD Million)
Table 82 Asia-Pacific: Other Drug Types Market, by Country, 2022-2030 (USD Million)
Table 83 Latin America: Other Drug Types Market, by Country, 2022-2030 (USD Million)
Table 84 Bph Surgical Treatment Market, by Type, 2022-2030 (USD Million)
Table 85 Bph Type Market, by Region, 2022-2030 (USD Million)
Table 86 North America: Bph Type Market, by Country, 2022-2030 (USD Million)
Table 87 Europe: Bph Type Market, by Country, 2022-2030 (USD Million)
Table 88 Asia-Pacific: Bph Type Market, by Country, 2022-2030 (USD Million)
Table 89 Latin America: Bph Type Market, by Country, 2022-2030 (USD Million)
Table 90 Bph Surgical Treatment Market for Turp, by Region, 2022-2030 (USD Million)
Table 91 North America: Bph Surgical Treatment Market for Turp, by Country, 2022-2030 (USD Million)
Table 92 Europe: Bph Surgical Treatment Market for Turp, by Country, 2022-2030 (USD Million)
Table 93 Asia-Pacific: Bph Surgical Treatment Market for Turp, by Country, 2022-2030 (USD Million)
Table 94 Latin America: Bph Surgical Treatment Market for Turp, by Country, 2022-2030 (USD Million)
Table 95 Bph Surgical Treatment Market for Laser Surgeries, by Region, 2022-2030 (USD Million)
Table 96 North America: Bph Surgical Treatment Market for Laser Surgeries, by Country, 2022-2030 (USD Million)
Table 97 Europe: Bph Surgical Treatment Market for Laser Surgeries, by Country, 2022-2030 (USD Million)
Table 98 Asia-Pacific: Bph Surgical Treatment Market for Laser Surgeries, by Country, 2022-2030 (USD Million)
Table 99 Latin America: Bph Surgical Treatment Market for Laser Surgeries, by Country, 2022-2030 (USD Million)
Table 100 Bph Surgical Treatment Market for Urolift Procedures, by Region, 2022-2030 (USD Million)
Table 101 North America: Bph Surgical Treatment Market for Urolift Procedures, by Country, 2022-2030 (USD Million)
Table 102 Europe: Bph Surgical Treatment Market for Urolift Procedures, by Country, 2022-2030 (USD Million)
Table 103 Asia-Pacific: Bph Surgical Treatment Market for Urolift Procedures, by Country, 2022-2030 (USD Million)
Table 104 Latin America: Bph Surgical Treatment Market for Urolift Procedures, by Country, 2022-2030 (USD Million)
Table 105 Bph Surgical Treatment Market for Rezum Procedures, by Region, 2022-2030 (USD Million)
Table 106 North America: Bph Surgical Treatment Market for Rezum Procedures, by Country, 2022-2030 (USD Million)
Table 107 Europe: Bph Surgical Treatment Market for Rezum Procedures, by Country, 2022-2030 (USD Million)
Table 108 Asia-Pacific: Bph Surgical Treatment Market for Rezum Procedures, by Country, 2022-2030 (USD Million)
Table 109 Latin America: Bph Surgical Treatment Market for Rezum Procedures, by Country, 2022-2030 (USD Million)
Table 110 Bph Surgical Treatment Market for Robot-Assisted Waterjet Ablation, by Region, 2022-2030 (USD Million)
Table 111 North America: Bph Surgical Treatment Market for Robot-Assisted Waterjet Ablation, by Country, 2022-2030 (USD Million)
Table 112 Europe: Bph Surgical Treatment Market for Robot-Assisted Waterjet Ablation, by Country, 2022-2030 (USD Million)
Table 113 Asia-Pacific: Bph Surgical Treatment Market for Robot-Assisted Waterjet Ablation, by Country, 2022-2030 (USD Million)
Table 114 Latin America: Bph Surgical Treatment Market for Robot-Assisted Waterjet Ablation, by Country, 2022-2030 (USD Million)
Table 115 Bph Surgical Treatment Market for Prostatic Stenting, by Region, 2022-2030 (USD Million)
Table 116 North America: Bph Surgical Treatment Market for Prostatic Stents, by Country, 2022-2030 (USD Million)
Table 117 Europe: Bph Surgical Treatment Market for Prostatic Stents, by Country, 2022-2030 (USD Million)
Table 118 Asia-Pacific: Bph Surgical Treatment Market for Prostatic Stents, by Country, 2022-2030 (USD Million)
Table 119 Latin America: Bph Surgical Treatment Market for Prostatic Stents, by Country, 2022-2030 (USD Million)
Table 120 Bph Surgical Treatment Market for Tumt, by Region, 2022-2030 (USD Million)
Table 121 North America: Bph Surgical Treatment Market for Tumt, by Country, 2022-2030 (USD Million)
Table 122 Europe: Bph Surgical Treatment Market for Tumt, by Country, 2022-2030 (USD Million)
Table 123 Asia-Pacific: Bph Surgical Treatment Market for Tumt, by Country, 2022-2030 (USD Million)
Table 124 Latin America: Bph Surgical Treatment Market for Tumt, by Country, 2022-2030 (USD Million)
Table 125 Bph Surgical Treatment Market for Tuna, by Region, 2022-2030 (USD Million)
Table 126 North America: Bph Surgical Treatment Market for Tuna, by Country, 2022-2030 (USD Million)
Table 127 Europe: Bph Surgical Treatment Market for Tuna, by Country, 2022-2030 (USD Million)
Table 128 Asia-Pacific: Bph Surgical Treatment Market for Tuna, by Country, 2022-2030 (USD Million)
Table 129 Latin America: Bph Surgical Treatment Market for Tuna, by Country, 2022-2030 (USD Million)
Table 130 Bph Surgical Treatment Market for Pae, by Region, 2022-2030 (USD Million)
Table 131 North America: Bph Surgical Treatment Market for Pae, by Country, 2022-2030 (USD Million)
Table 132 Europe: Bph Surgical Treatment Market for Pae, by Country, 2022-2030 (USD Million)
Table 133 Asia-Pacific: Bph Surgical Treatment Market for Pae, by Country, 2022-2030 (USD Million)
Table 134 Latin America: Bph Surgical Treatment Market for Pae, by Country, 2022-2030 (USD Million)
Table 135 Bph Surgical Treatment Market for Other Procedures, by Region, 2022-2030 (USD Million)
Table 136 North America: Bph Drug Treatment Market for Other Procedures, by Country, 2022-2030 (USD Million)
Table 137 Europe: Bph Drug Treatment Market for Other Procedures, by Country, 2022-2030 (USD Million)
Table 138 Asia-Pacific: Bph Drug Treatment Market for Other Procedures, by Country, 2022-2030 (USD Million)
Table 139 Latin America: Bph Drug Treatment Market for Other Procedures, by Country, 2022-2030 (USD Million)
Table 140 Bph Therapy Market, by Type, 2022-2030 (USD Million)
Table 141 Bph Therapy Market, by Region, 2022-2030 (USD Million)
Table 142 North America: Bph Therapy Market, by Country, 2022-2030 (USD Million)
Table 143 Europe: Bph Therapy Market, by Country, 2022-2030 (USD Million)
Table 144 Asia-Pacific: Bph Therapy Market, by Country, 2022-2030 (USD Million)
Table 145 Latin America: Bph Therapy Market, by Country, 2022-2030 (USD Million)
Table 146 Monotherapy Market, by Region, 2022-2030 (USD Million)
Table 147 North America: Monotherapy Market, by Country, 2022-2030 (USD Million)
Table 148 Europe: Monotherapy Market, by Country, 2022-2030 (USD Million)
Table 149 Asia-Pacific: Monotherapy Market, by Country, 2022-2030 (USD Million)
Table 150 Latin America: Monotherapy Market, by Country, 2022-2030 (USD Million)
Table 151 Combination Drug Therapy Market, by Region, 2022-2030 (USD Million)
Table 152 North America: Combination Drug Therapy Market, by Country, 2022-2030 (USD Million)
Table 153 Europe: Combination Drug Therapy Market, by Country, 2022-2030 (USD Million)
Table 154 Asia-Pacific: Combination Drug Therapy Market, by Country, 2022-2030 (USD Million)
Table 155 Latin America: Combination Drug Therapy Market, by Country, 2022-2030 (USD Million)
Table 156 Bph Surgical Treatment Market, by End-user, 2022-2030 (USD Million)
Table 157 Bph Surgical Treatment Market for Hospitals, by Region, 2022-2030 (USD Million)
Table 158 North America: Bph Surgical Treatment Market for Hospitals, by Country, 2022-2030 (USD Million)
Table 159 Europe: Bph Surgical Treatment Market for Hospitals, by Country, 2022-2030 (USD Million)
Table 160 Asia-Pacific: Bph Surgical Treatment Market for Hospitals, by Country, 2022-2030 (USD Million)
Table 161 Latin America: Bph Surgical Treatment Market for Hospitals, by Country, 2022-2030 (USD Million)
Table 162 Bph Surgical Treatment Market for Ascs & Clinics, by Region, 2022-2030 (USD Million)
Table 163 North America: Bph Surgical Treatment Market for Ascs & Clinics, by Country, 2022-2030 (USD Million)
Table 164 Europe: Bph Surgical Treatment Market for Ascs & Clinics, by Country, 2022-2030 (USD Million)
Table 165 Asia-Pacific: Bph Surgical Treatment Market for Ascs & Clinics, by Country, 2022-2030 (USD Million)
Table 166 Latin America: Bph Surgical Treatment Market for Ascs & Clinics, by Country, 2022-2030 (USD Million)
Table 167 Bph Surgical Treatment Market for Home Care Settings, by Region, 2022-2030 (USD Million)
Table 168 North America: Bph Surgical Treatment Market for Home Care Settings, by Country, 2022-2030 (USD Million)
Table 169 Europe: Bph Surgical Treatment Market for Home Care Settings, by Country, 2022-2030 (USD Million)
Table 170 Asia-Pacific: Bph Surgical Treatment Market for Home Care Settings, by Country, 2022-2030 (USD Million)
Table 171 Latin America: Bph Surgical Treatment Market for Home Care Settings, by Country, 2022-2030 (USD Million)
Table 172 Bph Surgical Treatment Market, by Region, 2022-2030 (USD Million)
Table 173 Global: Robot-Assisted Waterjet Ablation Systems Sold, 2022-2030 (Million Units)
Table 174 North America: Macroindicators
Table 175 North America: Bph Surgical Treatment Market, by Country, 2022-2030 (USD Million)
Table 176 North America: Bph Surgical Treatment Market, by Drug Type, 2022-2030 (USD Million)
Table 177 North America: Bph Surgical Treatment Market for Alpha-Blockers, by Type, 2022-2030 (USD Million)
Table 178 North America: Bph Surgical Treatment Market for 5-Alpha Reductase Inhibitors, by Type, 2022-2030 (USD Million)
Table 179 North America: Bph Surgical Treatment Market, by Type, 2022-2030 (USD Million)
Table 180 North America: Bph Surgical Treatment Market, by Therapy, 2022-2030 (USD Million)
Table 181 North America: Bph Surgical Treatment Market, by End-user, 2022-2030 (USD Million)
Table 182 US: Bph Surgical Treatment Market, by Drug Type, 2022-2030 (USD Million)
Table 183 US: Bph Surgical Treatment Market for Alpha-Blockers, by Type, 2022-2030 (USD Million)
Table 184 US: Bph Surgical Treatment Market for 5-Alpha Reductase Inhibitors, by Type, 2022-2030 (USD Million)
Table 185 US: Bph Surgical Treatment Market, by Type, 2022-2030 (USD Million)
Table 186 US: Bph Surgical Treatment Market, by Therapy, 2022-2030 (USD Million)
Table 187 US: Bph Surgical Treatment Market, by End-user, 2022-2030 (USD Million)
Table 188 Canada: Bph Surgical Treatment Market, by Drug Type, 2022-2030 (USD Million)
Table 189 Canada: Bph Surgical Treatment Market for Alpha-Blockers, by Type, 2022-2030 (USD Million)
Table 190 Canada: Bph Surgical Treatment Market for 5-Alpha Reductase Inhibitors, by Type, 2022-2030 (USD Million)
Table 191 Canada: Bph Surgical Treatment Market, by Type, 2022-2030 (USD Million)
Table 192 Canada: Bph Surgical Treatment Market, by Therapy, 2022-2030 (USD Million)
Table 193 Canada: Bph Surgical Treatment Market, by End-user, 2022-2030 (USD Million)
Table 194 Europe: Macroindicators
Table 195 Europe: Bph Surgical Treatment Market, by Country, 2022-2030 (USD Million)
Table 196 Europe: Bph Surgical Treatment Market, by Drug Type, 2022-2030 (USD Million)
Table 197 Europe: Bph Surgical Treatment Market for Alpha-Blockers, by Type, 2022-2030 (USD Million)
Table 198 Europe: Bph Surgical Treatment Market for 5-Alpha Reductase Inhibitors, by Type, 2022-2030 (USD Million)
Table 199 Europe: Bph Surgical Treatment Market, by Type, 2022-2030 (USD Million)
Table 200 Europe: Bph Surgical Treatment Market, by Therapy, 2022-2030 (USD Million)
Table 201 Europe: Bph Surgical Treatment Market, by End-user, 2022-2030 (USD Million)
Table 202 Germany: Bph Surgical Treatment Market, by Drug Type, 2022-2030 (USD Million)
Table 203 Germany: Bph Surgical Treatment Market for Alpha-Blockers, by Type, 2022-2030 (USD Million)
Table 204 Germany: Bph Surgical Treatment Market for 5-Alpha Reductase Inhibitors, by Type, 2022-2030 (USD Million)
Table 205 Germany: Bph Surgical Treatment Market, by Type, 2022-2030 (USD Million)
Table 206 Germany: Bph Surgical Treatment Market, by Therapy, 2022-2030 (USD Million)
Table 207 Germany: Bph Surgical Treatment Market, by End-user, 2022-2030 (USD Million)
Table 208 UK: Bph Surgical Treatment Market, by Drug Type, 2022-2030 (USD Million)
Table 209 UK: Bph Surgical Treatment Market for Alpha-Blockers, by Type, 2022-2030 (USD Million)
Table 210 UK: Bph Surgical Treatment Market for 5-Alpha Reductase Inhibitors, by Type, 2022-2030 (USD Million)
Table 211 UK: Bph Surgical Treatment Market, by Type, 2022-2030 (USD Million)
Table 212 UK: Bph Surgical Treatment Market, by Therapy, 2022-2030 (USD Million)
Table 213 UK: Bph Surgical Treatment Market, by End-user, 2022-2030 (USD Million)
Table 214 France: Bph Surgical Treatment Market, by Drug Type, 2022-2030 (USD Million)
Table 215 France: Bph Surgical Treatment Market for Alpha-Blockers, by Type, 2022-2030 (USD Million)
Table 216 France: Bph Surgical Treatment Market for 5-Alpha Reductase Inhibitors, by Type, 2022-2030 (USD Million)
Table 217 France: Bph Surgical Treatment Market, by Type, 2022-2030 (USD Million)
Table 218 France: Bph Surgical Treatment Market, by Therapy, 2022-2030 (USD Million)
Table 219 France: Bph Surgical Treatment Market, by End-user, 2022-2030 (USD Million)
Table 220 Italy: Bph Surgical Treatment Market, by Drug Type, 2022-2030 (USD Million)
Table 221 Italy: Bph Surgical Treatment Market for Alpha-Blockers, by Type, 2022-2030 (USD Million)
Table 222 Italy: Bph Surgical Treatment Market for 5-Alpha Reductase Inhibitors, by Type, 2022-2030 (USD Million)
Table 223 Italy: Bph Surgical Treatment Market, by Type, 2022-2030 (USD Million)
Table 224 Italy: Bph Surgical Treatment Market, by Therapy, 2022-2030 (USD Million)
Table 225 Italy: Bph Surgical Treatment Market, by End-user, 2022-2030 (USD Million)
Table 226 Spain: Bph Surgical Treatment Market, by Drug Type, 2022-2030 (USD Million)
Table 227 Spain: Bph Surgical Treatment Market for Alpha-Blockers, by Type, 2022-2030 (USD Million)
Table 228 Spain: Bph Surgical Treatment Market for 5-Alpha Reductase Inhibitors, by Type, 2022-2030 (USD Million)
Table 229 Spain: Bph Surgical Treatment Market, by Type, 2022-2030 (USD Million)
Table 230 Spain: Bph Surgical Treatment Market, by Therapy, 2022-2030 (USD Million)
Table 231 Spain: Bph Surgical Treatment Market, by End-user, 2022-2030 (USD Million)
Table 232 Rest of Europe: Bph Surgical Treatment Market, by Drug Type, 2022-2030 (USD Million)
Table 233 Rest of Europe: Bph Surgical Treatment Market for Alpha-Blockers, by Type, 2022-2030 (USD Million)
Table 234 Rest of Europe: Bph Surgical Treatment Market for 5-Alpha Reductase Inhibitors, by Type, 2022-2030 (USD Million)
Table 235 Rest of Europe: Bph Surgical Treatment Market, by Type, 2022-2030 (USD Million)
Table 236 Rest of Europe: Bph Surgical Treatment Market, by Therapy, 2022-2030 (USD Million)
Table 237 Rest of Europe: Bph Surgical Treatment Market, by End-user, 2022-2030 (USD Million)
Table 238 Asia-Pacific: Macroindicators
Table 239 Asia-Pacific: Bph Surgical Treatment Market, by Country, 2022-2030 (USD Million)
Table 240 Asia-Pacific: Bph Surgical Treatment Market, by Drug Type, 2022-2030 (USD Million)
Table 241 Asia-Pacific: Bph Surgical Treatment Market for Alpha-Blockers, by Type, 2022-2030 (USD Million)
Table 242 Asia-Pacific: Bph Surgical Treatment Market for 5-Alpha Reductase Inhibitors, by Type, 2022-2030 (USD Million)
Table 243 Asia-Pacific: Bph Surgical Treatment Market, by Type, 2022-2030 (USD Million)
Table 244 Asia-Pacific: Bph Surgical Treatment Market, by Therapy, 2022-2030 (USD Million)
Table 245 Asia-Pacific: Bph Surgical Treatment Market, by End-user, 2022-2030 (USD Million)
Table 246 Japan: Bph Surgical Treatment Market, by Drug Type, 2022-2030 (USD Million)
Table 247 Japan: Bph Surgical Treatment Market for Alpha-Blockers, by Type, 2022-2030 (USD Million)
Table 248 Japan: Bph Surgical Treatment Market for 5-Alpha Reductase Inhibitors, by Type, 2022-2030 (USD Million)
Table 249 Japan: Bph Surgical Treatment Market, by Type, 2022-2030 (USD Million)
Table 250 Japan: Bph Surgical Treatment Market, by Therapy, 2022-2030 (USD Million)
Table 251 Japan: Bph Surgical Treatment Market, by End-user, 2022-2030 (USD Million)
Table 252 China: Bph Surgical Treatment Market, by Drug Type, 2022-2030 (USD Million)
Table 253 China: Bph Surgical Treatment Market for Alpha-Blockers, by Type, 2022-2030 (USD Million)
Table 254 China: Bph Surgical Treatment Market for 5-Alpha Reductase Inhibitors, by Type, 2022-2030 (USD Million)
Table 255 China: Bph Surgical Treatment Market, by Type, 2022-2030 (USD Million)
Table 256 China: Bph Surgical Treatment Market, by Therapy, 2022-2030 (USD Million)
Table 257 China: Bph Surgical Treatment Market, by End-user, 2022-2030 (USD Million)
Table 258 India: Bph Surgical Treatment Market, by Drug Type, 2022-2030 (USD Million)
Table 259 India: Bph Surgical Treatment Market for Alpha-Blockers, by Type, 2022-2030 (USD Million)
Table 260 India: Bph Surgical Treatment Market for 5-Alpha Reductase Inhibitors, by Type, 2022-2030 (USD Million)
Table 261 India: Bph Surgical Treatment Market, by Type, 2022-2030 (USD Million)
Table 262 India: Bph Surgical Treatment Market, by Therapy, 2022-2030 (USD Million)
Table 263 India: Bph Surgical Treatment Market, by End-user, 2022-2030 (USD Million)
Table 264 Australia: Bph Surgical Treatment Market, by Drug Type, 2022-2030 (USD Million)
Table 265 Australia: Bph Surgical Treatment Market for Alpha-Blockers, by Type, 2022-2030 (USD Million)
Table 266 Australia: Bph Surgical Treatment Market for 5-Alpha Reductase Inhibitors, by Type, 2022-2030 (USD Million)
Table 267 Australia: Bph Surgical Treatment Market, by Type, 2022-2030 (USD Million)
Table 268 Australia: Bph Surgical Treatment Market, by Therapy, 2022-2030 (USD Million)
Table 269 Australia: Bph Surgical Treatment Market, by End-user, 2022-2030 (USD Million)
Table 270 Rest of Asia-Pacific: Bph Surgical Treatment Market, by Drug Type, 2022-2030 (USD Million)
Table 271 Rest of Asia-Pacific: Bph Surgical Treatment Market for Alpha-Blockers, by Type, 2022-2030 (USD Million)
Table 272 Rest of Asia-Pacific: Bph Surgical Treatment Market for 5-Alpha Reductase Inhibitors, by Type, 2022-2030 (USD Million)
Table 273 Rest of Asia-Pacific: Bph Surgical Treatment Market, by Type, 2022-2030 (USD Million)
Table 274 Rest of Asia-Pacific: Bph Surgical Treatment Market, by Therapy, 2022-2030 (USD Million)
Table 275 Rest of Asia-Pacific: Bph Surgical Treatment Market, by End-user, 2022-2030 (USD Million)
Table 276 Latin America: Macroindicators
Table 277 Latin America Bph Surgical Treatment Market, by Country, 2022-2030 (USD Million)
Table 278 Latin America: Bph Surgical Treatment Market, by Drug Type, 2022-2030 (USD Million)
Table 279 Latin America: Bph Surgical Treatment Market for Alpha-Blockers, by Type, 2022-2030 (USD Million)
Table 280 Latin America: Bph Surgical Treatment Market for 5-Alpha Reductase Inhibitors, by Type, 2022-2030 (USD Million)
Table 281 Latin America: Bph Surgical Treatment Market, by Type, 2022-2030 (USD Million)
Table 282 Latin America: Bph Surgical Treatment Market, by Therapy, 2022-2030 (USD Million)
Table 283 Latin America: Bph Surgical Treatment Market, by End-user, 2022-2030 (USD Million)
Table 284 Brazil: Bph Surgical Treatment Market, by Drug Type, 2022-2030 (USD Million)
Table 285 Brazil: Bph Surgical Treatment Market for Alpha-Blockers, by Type, 2022-2030 (USD Million)
Table 286 Brazil: Bph Surgical Treatment Market for 5-Alpha Reductase Inhibitors, by Type, 2022-2030 (USD Million)
Table 287 Brazil: Bph Surgical Treatment Market, by Type, 2022-2030 (USD Million)
Table 288 Brazil: Bph Surgical Treatment Market, by Therapy, 2022-2030 (USD Million)
Table 289 Brazil: Bph Surgical Treatment Market, by End-user, 2022-2030 (USD Million)
Table 290 Mexico: Bph Surgical Treatment Market, by Drug Type, 2022-2030 (USD Million)
Table 291 Mexico: Bph Surgical Treatment Market for Alpha-Blockers, by Type, 2022-2030 (USD Million)
Table 292 Mexico: Bph Surgical Treatment Market for 5-Alpha Reductase Inhibitors, by Type, 2022-2030 (USD Million)
Table 293 Mexico: Bph Surgical Treatment Market, by Type, 2022-2030 (USD Million)
Table 294 Mexico: Bph Surgical Treatment Market, by Therapy, 2022-2030 (USD Million)
Table 295 Mexico: Bph Surgical Treatment Market, by End-user, 2022-2030 (USD Million)
Table 296 Rest of Latin America: Bph Surgical Treatment Market, by Drug Type, 2022-2030 (USD Million)
Table 297 Rest of Latin America: Bph Surgical Treatment Market for Alpha-Blockers, by Type, 2022-2030 (USD Million)
Table 298 Rest of Latin America: Bph Surgical Treatment Market for 5-Alpha Reductase Inhibitors, by Type, 2022-2030 (USD Million)
Table 299 Rest of Latin America: Bph Surgical Treatment Market, by Type, 2022-2030 (USD Million)
Table 300 Rest of Latin America: Bph Surgical Treatment Market, by Therapy, 2022-2030 (USD Million)
Table 301 Rest of Latin America: Bph Surgical Treatment Market, by End-user, 2022-2030 (USD Million)
Table 302 Middle East & Africa: Macroindicators
Table 303 Middle East & Africa: Bph Surgical Treatment Market, by Drug Type, 2022-2030 (USD Million)
Table 304 Middle East & Africa: Bph Surgical Treatment Market for Alpha-Blockers, by Type, 2022-2030 (USD Million)
Table 305 Middle East & Africa: Bph Surgical Treatment Market for 5-Alpha Reductase Inhibitors, by Type, 2022-2030 (USD Million)
Table 306 Middle East & Africa: Bph Surgical Treatment Market, by Type, 2022-2030 (USD Million)
Table 307 Middle East & Africa: Bph Surgical Treatment Market, by Therapy, 2022-2030 (USD Million)
Table 308 Middle East & Africa: Bph Surgical Treatment Market, by End-user, 2022-2030 (USD Million)
Table 309 GCC Countries: Macroindicators
Table 310 GCC Countries: Bph Surgical Treatment Market, by Drug Type, 2022-2030 (USD Million)
Table 311 GCC Countries: Bph Surgical Treatment Market for Alpha-Blockers, by Type, 2022-2030 (USD Million)
Table 312 GCC Countries: Bph Surgical Treatment Market for 5-Alpha Reductase Inhibitors, by Type, 2022-2030 (USD Million)
Table 313 GCC Countries: Bph Surgical Treatment Market, by Type, 2022-2030 (USD Million)
Table 314 GCC Countries: Bph Surgical Treatment Market, by Therapy, 2022-2030 (USD Million)
Table 315 GCC Countries: Bph Surgical Treatment Market, by End-user, 2022-2030 (USD Million)
Table 316 Overview of Strategies Adopted by Key Market Players
Table 317 Bph Surgical Treatment Market, by Drug Type: Degree of Competition
Table 318 Bph Surgical Treatment Market, by Type: Degree of Competition
Table 319 Bph Surgical Treatment Market: Company Footprint
Table 320 Bph Surgical Treatment Market: Region Footprint
Table 321 Bph Surgical Treatment Market: Drug Type Footprint
Table 322 Bph Surgical Treatment Market: Type Footprint
Table 323 Bph Surgical Treatment Market: End-user Footprint
Table 324 Bph Surgical Treatment Market: Detailed List of Key SME Players
Table 325 Bph Surgical Treatment Market: Competitive Benchmarking of Key Startups
Table 326 Bph Surgical Treatment Market: Product Launches & Approvals, January 2021-January 2025
Table 327 Bph Surgical Treatment Market: Deals, January 2021-January 2025
Table 328 Bph Surgical Treatment Market: Expansions, January 2021-January 2025
Table 329 GlaxoSmithKline PLC: Company Overview
Table 330 GlaxoSmithKline PLC: Products Offered
Table 331 GlaxoSmithKline PLC: Deals, January 2021-January 2025
Table 332 Eli Lilly and Company: Company Overview
Table 333 Eli Lilly and Company: Products Offered
Table 334 Eli Lilly and Company: Deals, January 2021-January 2025
Table 335 Teleflex Incorporated: Company Overview
Table 336 Teleflex Incorporated: Products Offered
Table 337 Teleflex Incorporated: Product Launches & Approvals, January 2021-January 2025
Table 338 Boston Scientific Corporation: Company Overview
Table 339 Boston Scientific Corporation: Products Offered
Table 340 Boston Scientific Corporation: Deals, January 2021-January 2025
Table 341 Boston Scientific Corporation: Expansions, January 2021-January 2025
Table 342 Procept Biorobotics Corporation: Company Overview
Table 343 Procept Biorobotics Corporation: Products Offered
Table 344 Procept Biorobotics Corporation: Product Launches & Approvals, January 2021-January 2025
Table 345 Procept Biorobotics Corporation: Expansions, January 2021-January 2025
Table 346 Astellas Pharma Inc.: Company Overview
Table 347 Astellas Pharma Inc.: Products Offered
Table 348 Alembic Pharmaceuticals Limited: Company Overview
Table 349 Alembic Pharmaceuticals Limited: Products Offered
Table 350 Asahi Kasei Corporation: Company Overview
Table 351 Asahi Kasei Corporation: Products Offered
Table 352 Organon & Co.: Company Overview
Table 353 Organon & Co.: Products Offered
Table 354 Organon & Co.: Deals, January 2021-January 2025
Table 355 Olympus Corporation: Company Overview
Table 356 Olympus Corporation: Products Offered
Table 357 Olympus Corporation: Deals, January 2021-January 2021
Table 358 Coloplast Group: Company Overview
Table 359 Coloplast Group: Products Offered
Table 360 Ipg Photonics Corporation: Company Overview
Table 361 Ipg Photonics Corporation: Products Offered
Table 362 Viatris Inc.: Company Overview
Table 363 Viatris Inc.: Products Offered
Table 364 Abbvie Inc.: Company Overview
Table 365 Abbvie Inc.: Products Offered
Table 366 Abbvie Inc.: Deals, January 2021-January 2025
Table 367 Prostalund Ab: Company Overview
Table 368 Prostalund Ab: Products Offered

Figure 1 Markets & Regions Covered
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: Supply-Side and Demand-Side Participants
Figure 4 Breakdown of Primary Interviews: by Company Type, Designation, and Region
Figure 5 Bph Surgical Treatment Market: Revenue Estimation Approach, by Type
Figure 6 Bph Surgical Treatment Market: Revenue Estimation Approach, by Drug Type
Figure 7 CAGR Projections: Supply-Side Analysis
Figure 8 Bph Surgical Treatment Market: Top-Down Approach
Figure 9 Data Triangulation Methodology
Figure 10 Bph Surgical Treatment Market, by Drug Type, 2024 vs. 2030 (USD Million)
Figure 11 Bph Surgical Treatment Market, by Type, 2024 vs. 2030 (USD Million)
Figure 12 Bph Surgical Treatment Market, by Therapy, 2024 vs. 2030 (USD Million)
Figure 13 Bph Surgical Treatment, by End-user, 2024 vs. 2030 (USD Million)
Figure 14 Geographic Snapshot of Bph Surgical Treatment Market
Figure 15 Expanding Geriatric Population and Increasing Prevalence of Benign Prostatic Hyperplasia to Propel Market
Figure 16 Alpha-Blockers Segment Accounted for Largest Market Share in US in 2023
Figure 17 China to Register Highest Growth Rate During Forecast Period
Figure 18 Asia-Pacific Region to Grow at Highest CAGR During Forecast Period
Figure 19 Bph Treatment Market: Drivers, Restraints, Opportunities, and Challenges
Figure 20 Bhp Surgical Treatment Market: Major Value Added During Manufacturing & Assembly Phases
Figure 21 Bph Surgical Treatment Market: Supply Chain Analysis
Figure 22 Bph Surgical Treatment Market: Ecosystem Analysis
Figure 23 Key Players in Bph Surgical Treatment Market Ecosystem
Figure 24 Bph Surgical Treatment Market: Porter's Five Forces Analysis
Figure 25 Influence of Stakeholders on Buying Process for Bph Surgical Treatment Market
Figure 26 Key Buying Criteria for Bph Surgical Treatment, by End-user
Figure 27 Bph Surgical Treatment Market: PESTLE Analysis
Figure 28 Patent Analysis for Prostatic Stents: January 2015-December 2024
Figure 29 Patent Analysis for Transurethral Catheters: January 2015-December 2024
Figure 30 Patent Analysis for Avodart: January 2015-December 2024
Figure 31 Patent Analysis for Alfuzosin: January 2015-December 2024
Figure 32 Trends and Disruptions Impacting Customer Businesses in Bph Surgical Treatment Market
Figure 33 Bph Surgical Treatment Market: Number of Deals & Ventures
Figure 34 North America: Bph Surgical Treatment Market Snapshot
Figure 35 Asia-Pacific: Bph Surgical Treatment Market Snapshot
Figure 36 Revenue Analysis of Key Players in Bph Surgical Treatment, 2021-2023
Figure 37 Market Share Analysis of Key Players in Bph Surgical Treatment Market, by Drug Type (2023)
Figure 38 Market Share Analysis of Key Players in Bph Surgical Treatment Market, by Type (2023)
Figure 39 Bph Surgical Treatment Market: Company Evaluation Matrix for Drug Type (Key Players), 2023
Figure 40 Bph Surgical Treatment Market: Company Evaluation Matrix for Type, (Key Players), 2023
Figure 41 Bph Surgical Treatment Market: Company Evaluation Matrix (Startups/SMEs), 2023
Figure 42 EV/EBITDA of Key Vendors, 2023-2024
Figure 43 Year-To-Date (Ytd) Price Total Return and 5-Year Stock Beta of Key Vendors
Figure 44 Bph Surgical Treatment Market: Brand/Product Comparative Analysis
Figure 45 GlaxoSmithKline PLC: Company Snapshot (2023)
Figure 46 Eli Lilly and Company: Company Snapshot (2023)
Figure 47 Teleflex Incorporated: Company Snapshot (2023)
Figure 48 Boston Scientific Corporation: Company Snapshot (2023)
Figure 49 Procept Biorobotics Corporation: Company Snapshot (2023)
Figure 50 Astellas Pharma Inc.: Company Snapshot (2023)
Figure 51 Alembic Pharmaceuticals Limited: Company Snapshot (2023)
Figure 52 Asahi Kasei Corporation: Company Snapshot (2023)
Figure 53 Organon & Co.: Company Snapshot (2023)
Figure 54 Olympus Corporation: Company Snapshot (2023)
Figure 55 Coloplast Group: Company Snapshot (2024)
Figure 56 Ipg Photonics Corporation: Company Snapshot (2023)
Figure 57 Viatris Inc.: Company Snapshot (2023)
Figure 58 Abbvie Inc.: Company Snapshot (2023)
Figure 59 Prostalund Ab: Company Snapshot (2023)